Health and financial effects of changing abortion access
Health and economic consequences of changing federal and state policies on reproductive health.
This project compares short- and long-term health and financial impacts on people who sought abortions before and after state bans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11367891 on NIH RePORTER |
What this research studies
You would be followed over time to document what happened after you tried to get an abortion, including health, economic, and caregiving outcomes. The team uses surveys, clinic records, and other data to compare people who were served before a ban with people who sought care right after a ban went into effect. The study includes people of reproductive capacity such as women, trans men, and non-binary people and tracks immediate and longer-term effects. Researchers aim to capture both medical outcomes and financial and logistic burdens like travel and childcare.
Who could benefit from this research
Good fit: Ideal candidates are people who sought an abortion around the time a state-level ban was implemented, including women, trans men, and non-binary people capable of pregnancy.
Not a fit: People who were not seeking abortion care or who live in areas with no change in abortion policy are unlikely to see direct benefit from participating.
Why it matters
Potential benefit: If successful, this work could clarify how policy changes affect people's health and finances so policymakers and clinics can better support those affected.
How similar studies have performed: Previous observational work (for example, the Turnaway Study) found negative health and economic effects after denied abortions, and this project applies a new rapid-response design to the post-2022 policy changes.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Foster, Diana Greene — University of California, San Francisco
- Study coordinator: Foster, Diana Greene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.